Profits Comeback Paired With Rate Cuts Make a Powerful Mix

Profits are growing again, and the Federal Reserve looks as if it will start cutting rates…

A Tale of Two Pharmas: Can Obesity Firms Continue Their Outperformance in 2024?

In pharma, you can take a larger slice of the healthcare pie than your peers, but…

The Score: Macy’s, Hasbro, Pfizer and More Stocks That Defined the Week

The Score is a weekly review of the biggest stock moves and the news that drove…

Microsoft Tops the List of Best-Managed Companies of 2023

Journal Reports: Leadership What’s New in the Best Managed Companies Rankings in 2023 By Rick Wartzman…

The Score: Shopify, GM, Tesla and More Stocks That Defined the Week

The Score is a weekly review of the biggest stock moves and the news that drove…

WSJ News Exclusive | Ranking the Best Companies for Career Growth

Updated Nov. 30, 2023 10:13 am ET Listen to article (2 minutes) Looking to get promoted…

Earnings Estimates Are Falling. These Two Companies Are Shouldering the Blame.

Wall Street has slashed its estimates for corporate profits in the final months of 2023. Yet…

Never Mind Covid, Investors Want a Pfizer Obesity Pill

Some of this year’s best performers in the healthcare sector are companies expected to profit from…

‘Guided Missile Drugs’ Could Be Big Pharma’s Secret Weapon

Merck and Pfizer are the latest big pharma companies to invest in this booming area.

This $5 Billion Biotech Home Run Took Less Than a Year

You can’t completely blame Pfizer’s executives, yet Roche’s $7 billion acquisition of a bowel-disease treatment that…